30.09
-0.81(-2.62%)
Currency In USD
| Previous Close | 30.9 |
| Open | 30.55 |
| Day High | 31.09 |
| Day Low | 29.87 |
| 52-Week High | 46.48 |
| 52-Week Low | 25.28 |
| Volume | 1.96M |
| Average Volume | 1.86M |
| Market Cap | 4.78B |
| PE | 10.86 |
| EPS | 2.77 |
| Moving Average 50 Days | 29.91 |
| Moving Average 200 Days | 32.75 |
| Change | -0.81 |
If you invested $1000 in TG Therapeutics, Inc. (TGTX) 10 years ago, it would be worth $3,612.24 as of February 28, 2026 at a share price of $30.09. Whereas If you bought $1000 worth of TG Therapeutics, Inc. (TGTX) shares 4 years ago, it would be worth $668.67 as of February 28, 2026 at a share price of $30.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
GlobeNewswire Inc.
Feb 23, 2026 12:30 PM GMT
Conference Call to be Held Thursday, February 26, 2026, at 8:30 am ETNEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Thursday, February 26, 2026, at 8:30 AM ET t
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
GlobeNewswire Inc.
Feb 17, 2026 12:30 PM GMT
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50 years of patient treatment Overall safety profile of BRIUMVI remained consistent over 5 years of continuous treatment, with no
TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis
GlobeNewswire Inc.
Feb 08, 2026 9:17 PM GMT
Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among people living with MS A Media Snippet accompanying this announcement is available by clicking on this link. N